BLa80: Mainland China’s First Probiotic Strain Approved for Infant Nutrition

Wecare Probiotics' Bifidobacterium animalis subsp. lactis BLa80 has achieved historic triple recognition:

First Mainland China Strain on National Whitelist: BLa80 is the first probiotic from mainland China approved for use in infant and young children’s food by the China National Health Commission.

Dual GRAS Certification: BLa80 is the first Chinese strain to secure both self-affirmed GRAS and FDA GRAS status, meeting rigorous U.S. safety standards.

EFSA QPS Inclusion: BLa80 is recognized on the European Food Safety Authority’s Qualified Presumption of Safety (QPS) list, affirming its global safety compliance.

Unmatched Safety and Quality

Derived from healthy human breast milk, BLa80 is naturally suited for infants. Genomic analysis confirms its safety, with no virulence genes detected, ensuring it meets the highest safety standards. With a robust viable cell count (up to 600 billion CFU per serving), BLa80 delivers consistent potency. Extensive clinical research, including a 2025 randomized controlled trial, demonstrates BLa80’s ability to improve sleep quality, gut microbiota balance, and reduce symptoms like cough, fever, dry stool, and eczema in children.

A New Choice for Infant Health

With its proven safety, high viable cell counts, and deep clinical backing, BLa80 is transforming infant and young children's health worldwide, standing alongside other globally recognized probiotic strains.

Learn More: www.wecare-life.com
Contact Us: sales@wecare-life.com